Qbm076

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Qbm076 is an investigational medication currently being studied by Novartis Pharmaceuticals. It is being evaluated in clinical trials, often in combination with other agents, to determine its safety and potential effectiveness. The specific role of Qbm076 in colorectal cancer treatment is still under investigation. Clinical trials are designed to find the right dose and schedule for the drug and to see if it has any activity against the cancer. The trials often include patients with specific characteristics, such as certain levels of PD-L1 expression, to help understand which patients might benefit most.

Mechanism of Action

The specific mechanism of action for Qbm076 is being investigated in clinical trials. It is being studied in combination with other agents that have immunomodulatory activity, suggesting it may interact with the body's immune system to fight cancer. The exact molecular target or pathway affected by Qbm076 is not yet fully defined.

Side Effects

As Qbm076 is an investigational drug Its side effects are still being evaluated in ongoing clinical trials. The safety and tolerability of Qbm076 Especially when combined with other medications Are key aspects being assessed in these studies. Information about specific side effects will become clearer as more data is collected from the trials.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT02890069 Phase 1
Archived
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
United States, Germany, Netherlands, South Korea, Spain, Taiwan, United Kingdom

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.